Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Burning Issues
Case Report
Case Reports
Current Issue
Expert Commentary
Invited Editorial
Letter to the Editor
LetterTo Editor
MEDic LAWgic Series
Narrative Review
Original Article
Pictorial Update
Review Article
View/Download PDF

Translate this page into:

Original Article
73 (
); 327-330

Hemoglobinopathy in pediatric population: A cross sectional study at tertiary care center in Assam

Department of Neonatology, IPGMER, Kolkata, West Bengal, India
Department of Pediatrics, Assam Medical College, Dibrugarh, Assam, India
Corresponding author: Uttam Kumar Mondal, Department of Neonatology, IPGMER, 244, A.J.C Bose Road, Bhowanipur, Kolkata - 700 020, West Bengal, India.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Mondal UK, Dowerah P, Mukherjee R. Hemoglobinopathy in pediatric population: A cross sectional study at tertiary care center in Assam. Indian J Med Sci 2021;73:327-30.



The objectives of the study were to find out the prevalence, epidemiology, and clinicohematological profile of hemoglobinopathies.

Material and Methods:

During the period of September 2010–August 2011, an observational study was done in the Department of Pediatrics, Assam Medical College and Hospital, Dibrugarh. Children (<12 years) suffering from chronic anemia were the study population.


Hemoglobinopathies were noted in 72 (35.0%) out of 206 chronic anemia cases, of which sickle cell disease (SCD) was found in 23 cases (11.2%), beta-thalassemia major (BTM) in 21 cases (10.2%), hemoglobin E (HbE)-β thalassemia in 12 cases (5.8%), HbE disease was seen in 10 cases (4.8%), and HbE trait and sickle cell trait (SCT) in 3 cases each. Overall hemoglobinopathy was most commonly seen among teagarden community in Assam. Clinical presentation ranged from completely asymptomatic to congestive heart failure. In majority cases, decreased mean Hb (%) and mean corpuscular volume were found. Anisopoikilocytosis, reticulocytosis, and target cells were frequently noted in peripheral blood smear.


Chronic anemia cases should be screened for hemoglobinopathies as these genetic disorders are commonly seen in Assam. SCD and BTM are the major types of hemoglobinopathies. Heterozygous hemoglobinopathies (HbE trait and SCT) had lesser clinical manifestations. As the definitive treatment of hemoglobinopathies is still difficult to avail in this region, genetic counseling should be considered for hemoglobinopathy patients and their families as well, to prevent new cases.


Hemoglobin E-β thalassemia
Sickle cell disease


Anemia is a major health problem in pediatric populations of India. In a study from South India, the prevalence of anemia in school-going children (6–12 years) was found to be 53.6%.[1] The prevalence of anemia among 6–59-month-old children in India is 58.6% whereas it is 35.7% in Assam as per NFHS-4 data. Many factors are responsible for childhood anemia, for example, undernutrition, iron and vitamin deficiency, tuberculosis, HIV, chronic infections, malaria, etc. With the advancement in diagnosis and public health management through different ongoing national health programs, congenital hemolytic anemia has come to the forefront as predominant cause of anemia in children.

Inherited disorders of hemoglobin (Hb) are the most common genetic disorders with 7% of the world population being carriers but their frequency and distribution varies among different racial and ethnic groups.[2]


This study was carried out in the Pediatric Department of Assam Medical College Hospital, Dibrugarh. Children aged up to 12 years were recruited during the period of September 2010–August 2011.

Inclusion criteria

Both inpatient and outpatient children with chronic anemia were included in the study.

Exclusion criteria

Children who had received blood transfusion within the past 4 months of recruitment were excluded from the study.

A pro forma was prepared for recording patient’s identification, particulars, presenting complains, general and systemic examination, anthropometric measurements, and relevant laboratory investigations.

Blood was collected for the following tests:

  1. Complete hemogram

  2. Sickling test

  3. Reticulocyte count

  4. High-performance liquid chromatography (HPLC) for Hb fractions.


In our study, 206 children suffering from chronic anemia formed the study population. Of which, 72 cases (35.0 %) were found to have hemoglobinopathies by HPLC.

The prevalence of individual hemoglobinopathies was as follows, sickle cell anemia disease (SCD) was found in 23 cases (11.2%), beta-thalassemia major (BTM) in 21 cases (10.2%), HbE-β thalassemia 12 cases (5.8%), HbE disease in 10 cases (4.8%), and HbE trait and sickle cell trait (SCT) in 3 cases each (1.5% each).

We found a male preponderance in general, female preponderance among HbE trait and no sex difference was found in cases of HbE disease.

Age distribution showed that the youngest case was a 7-month-old boy suffering from BTM and the oldest was an 11-year-old girl with HbE trait. Mean age was 6.76 years.

Overall incidence of hemoglobinopathies was highest in teagarden community 40 (55.6%), followed by Ahom 14 (19.44%). Among different hemoglobinopathies, HbE was mostly found in Ahom community and Hb S in tea garden community [Table 1].

Table 1:: Distribution of cases by caste and community.
Hemoglobinopathies Communities
Ahom (%) Chutia (%) Bengali Hindu (%) Teagarden (%) Muslim (%) Kayastha (%) Nepali (%) Sonowal-Kachari (%)
Total=72 14 (19.6) 2 (2.8) 3 (4.1) 40 (55.6) 3 (4.1) 4 (5.6) 3 (4.1) 3 (4.1)
HbE disease 4 (5.6) 1 (1.4) 0 2 (2.8) 1 (1.4) 0 0 2 (2.8)
HbE trait 2 (2.8) 1 (1.4) 0 0 0 0 0 0
HbE-β-thalassemia 4 (5.6) 0 0 3 (4.2) 2 (2.8) 1 (1.4) 1 (1.4) 1 (1.4)
β-thalassemia major 4 (5.6) 0 2 (2.8) 11 (15.2) 0 2 (2.8) 2 (2.8) 0
Sickle cell disease 0 0 1 (1.4) 21 (29.2) 0 1 (1.4) 0 0
Sickle cell trait 0 0 0 3 (4.2) 0 0 0 0

HbE: Hemoglobin E

In addition to anemia, splenomegaly (i.e., >4 cm) was a predominant clinical features of BTM, SCD, and cases of HbE-beta-thalassemia [Table 2].

Table 2:: Clinical signs and symptoms in different hemoglobinopathies.
Signs-symptoms anthropometry Sickle cell disease Sickle cell trait HbE disease HbE trait HbE-beta- thalassemia Beta-thalassemia major
Total cases=23 Total cases=3 Total cases=10 Total cases=3 Total cases=12 Total cases=21
n % n % n % n % n % n %
Pallor 18 78.3 2 66.7 9 90 3 100 12 100 21 100
Generalized weakness 23 100 2 66.7 7 70 0 0 11 91.6 21 100
Hemolytic facies 7 30.4 0 0 3 30 0 0 9 75 16 76.2
Jaundice 15 65.2 1 33.3 5 50 0 0 3 25 11 52.4
Joint pain 7 30.4 2 66.7 0 0 0 0 0 0 0 0
Pedal edema 1 4.34 0 0 1 10 0 0 1 8.3 2 9.52
Hepatomegaly 23 100 2 66.7 3 30 0 0 10 83.3 19 90.4
Congestive heart failure 1 4.34 0 0 0 0 0 0 1 8.3 1 4.75
Splenomegaly 23 100 0 0 7 70 0 0 11 91.6 21 100
Stunted 7 30.4 0 0 0 0 0 0 7 58.3 17 80.9
Wasted 14 60.8 3 100 5 50 0 0 11 91.6 19 90.4

HbE: Hemoglobin E

Laboratory investigations revealed mean Hb of 5.74 g/dl for all hemoglobinopathies. Lowest Hb was 1.3 g/dl in case of BTM. Mean corpuscular volume (MCV) was 71.7fl, mean corpuscular hemoglobin (MCH) was 23.2 pg, and red cell diameter width (RDW) was 23.8 [Table 3].

Table 3:: Hb fractions and RBC indices in various hemoglobinopathies.
HPLC diagnosis No. Hb (g/dl) RBC (/1012/L) MCV (fl) MCH (pg) MCHC (g/dl) RDW HbA% HbA2/E% HbF% HbS%
HbE disease 10 6.4±3.2 3.9±0.5 60.1±2.1 22.5±1.7 31.1±2.3 18.0±1.1 4.5±0.0 71.6±1.0 4.8±0.9 0±0
HbE trait 3 5.36±4.6 3.8±1.3 78.6±0.7 24.5±0.8 31.6±0.9 15.7±0.4 54.6±0.1 26.0±1.6 8.1±0.3 0±0
HbE-beta-thalassemia 12 5.8±1.1 3.7±0.7 67.1±4.2 20.8±2.7 29.6±3.4 26.3±1.4 3.8±0.2 38.2±1.0 50.5±6.3 0±0
Beta-thalassemia major 21 5.3±0.7 3.8±1.2 64.7±9.2 21.7±3.2 34.7±3.2 27.3±1.5 7.5±1.97 6.2±2.1 82.9±6.2 0±0
Sickle cell disease 23 6.0±0.0 4.2±0.0 81.3±8.5 25.1±3.2 29.1±1.5 22.9±2.0 2.5±1.3 3.4±0.5 20.4±0.1 70.9±1.6
Sickle cell trait 3 5.1±0.0 4.0±0.0 98.7±15.6 31.9±8.9 31.4±4.3 24.3±5.1 51.6±9.6 5.1±0.6 5.8±3.0 29.3±7.4

Hb: Hemoglobin, HbE: Hemoglobin E, RBC: Red blood cell, MCV: Mean corpuscular volume, MCH: Mean corpuscular hemoglobin, MCHC: Mean corpuscular hemoglobin concentration; RDW: Red cell diameter width, HbA: Hemoglobin A, HbA2: Hemoglobin A2, HbF: Hemoglobin F, HbS: Hemoglobin S, HPLC: High-performance liquid chromatography

HPLC showed that mean level of Hb A was 8.7%, Hb A2 was 20.65%, and Hb F was 40.3%.

Few patients had clinical presentations other than anemia (febrile convulsion, pneumonia, etc.) where laboratory features indicated hemolysis. The diagnosis was confirmed by HPLC.


Assam has a mixed population with an ethnic link of Southeast Asia, Aryans, immigrant Oryahs comprising the tea garden laborers, migrating population from other states, Bengalis.[3]

In our study, the prevalence of hemoglobinopathies was almost 35.0% while the study by Warghade et al. for abnormal Hb had shown a rate of 18.44% and Sanghavi et al. as 27%.[4,5] In the study by Warghade et al., a large population (n = 65779) from all over India of all age groups was screened to identify Hb fractions prevalent in India whereas our study incorporated a small number (n = 206) of sick children, specifically suffering from chronic anemia and resident of a state which is a known reservoir for hemoglobinopathies. The prevalence of abnormal Hb variants was 59.11%, as seen by Baruah et al. in his laboratory-based study involving all age groups from Assam.[6] In another study by Kalita et al. involving 100 individuals of all age groups, prevalence was 55%.[7] Borah et al. from Gauhati Medical College showed prevalence of hemoglobinopathies as 67.46% in a hospital-based study.[8]

A male preponderance was noted in our study as well as by Sanghavi et al. – 61% and 59.2%, respectively.[5]

In the all India study by Warghade et al., most prevalent hemoglobinopathy was found to be beta-thalassemia trait(11.2%).[4] Various researchers from Assam have reported HbE trait as most prevalent (varying from 20% to 55%) hemoglobinopathy followed by HbE disease.[6,7,9] Different states of the Northeastern region show a variable incidence of HbE varying from 16.2% to 47.3%.[9-12] At the same time, huge migrant tea garden population shows a high incidence of HbS in this part of India.[13,14] In our study, sickle cell anemia was the most prevalent hemoglobinopathy (11.2%) whereas HbE disease had a prevalence of 4.8%. In the study by Sanghavi et al., most prevalent hemoglobinopathy was sickle cell anemia.[5]

Kalita et al have reported Ahom community as most commonly affected whereas in our study, hemoglobinopathies were mostly noted among tea garden workers.[7]

This variation of the prevalence of hemoglobinopathies (total and individual) in different studies actually reflects the fact that hemoglobinopathy is a genetic disorder which is clustered among few particular communities and also the Indian practice of marriages into same community. In our study, tea garden community was predominant, as our hospital was the main referral center for tea garden hospitals. Tea garden community consists of tribal population, originally from Orissa, Chotanagpur, Andhra Pradesh, and Jharkhand where HbS gene is more common than others.[3,15]

In the hematological parameters, we found that mean Hb for BTM and SCD was 5.3 ± 0.7 g/dl and 6.0 ± 0.0 g/dl, respectively. Sanghavi et al. reported quite similar values for mean Hb of 6.28 ± 1.75 g/dl and 6.5 ± 1.7 g/dl, respectively, for BTM and SCD. Our values of MCV and MCH regarding BTM tally with those of Sanghavi et al. but these RBC parameters differ in case of SCD. HPLC findings in both BTM and SCD in our and as well as in the study by Sanghavi et al are comparable.[5]


We could conclude that SCD is commonly found among migrant tea garden workers whereas HbE among native population. Thalassemias, both homo and heterozygous were more severe than other varieties.


I thank the faculties of the Department of Pediatrics, Assam Medical College, Dibrugarh, and my colleagues at both Assam Medical College, Dibrugarh, and IPGMER and SSKM Hospital, Kolkata.

Declaration of patient consent

Patient’s consent not required as patients identity is not disclosed or compromised.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


  1. , . Study of prevalence of anemia in school children and factors associated with it. Int J Contemp Med Res. 2017;4:1902-5.
    [Google Scholar]
  2. , , , , . Disease Control Priorities in Developing Countries (2nd ed). New York: Oxford University Press; .
    [Google Scholar]
  3. . Hemoglobin E in Northeast India: A review on its origin, distribution, migration and health implication. Anthropol Rev. 2016;79:241-63.
    [CrossRef] [Google Scholar]
  4. , , , , , , et al. Prevalence of hemoglobin variants and hemoglobinopathies using cation-exchange high-performance liquid chromatography in central reference laboratory of India: A report of 65779 cases. J Lab Physicians. 2018;10:73-9.
    [CrossRef] [PubMed] [Google Scholar]
  5. , . Profile of anemia with special reference to hemoglobinopathies in a tertiary care centre in Madhya Pradesh. Pediatr Rev Int J Pediatr Res. 2015;2:143-51.
    [CrossRef] [Google Scholar]
  6. , , . Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: High performance liquid chromatography studies in 9000 patients. Indian J Pathol Microbiol. 2014;57:236-43.
    [CrossRef] [PubMed] [Google Scholar]
  7. , . A cross sectional study of haemoglobin variants in north East India. Indian J Basic Appl Med Res. 2016;5:72-9.
    [Google Scholar]
  8. , , . Occurrence of haemoglobinopathies and thalassaemia in North East India a hospital based study. Online J Biosci Inform. 2013;5:309-506.
    [Google Scholar]
  9. , , , , , , et al. Anemia and hemoglobinopathies in tribal population of Eastern and North-eastern India. Hematology. 2006;11:371-3.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , , . Screening for haemoglobinopathies and G6PD deficiency among the Mizos of Mizoram: A preliminary study. Indian J Pathol Microbiol. 2005;48:17-8.
    [Google Scholar]
  11. , . HbE genotypes and fertility: A study on a Tibeto-Burmese population in Upper Assam, India. Ann Hum Biol. 2008;35:422-31.
    [CrossRef] [PubMed] [Google Scholar]
  12. , . Genetic polymorphisms at three loci in two populations of Manipur, India. Anthropol Anz. 2008;66:191-8.
    [CrossRef] [Google Scholar]
  13. . Epidemiology, population health genetics and phenotypic diversity of sickle cell disease in India. Internet J Biol Anthropol. 2007;1:2.
    [CrossRef] [Google Scholar]
  14. , . Prevalence of haemoglobin variants in malariaendemic Northeast India. J Biol Sci. 2009;9:288-91.
    [CrossRef] [Google Scholar]
  15. . Epidemiology of Sickle Haemoglobin in India. Available from: [Last accessed on 2020 Oct 03]
    [Google Scholar]
Show Sections